Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test

NCT01740687 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01740687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01740687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
November 13, 2012
Completion date
June 14, 2021
Enrollment
211 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

contraception, menorrhagia